Neurocrine Biosciences Market Cap

Neurocrine Biosciences has a market cap or net worth of $14.14 billion as of May 21, 2024. Its market cap has increased by 49.89% in one year.

Market Cap

14.14B

Enterprise Value

13.45B

1-Year Change

49.89%

Ranking

#670

Market Cap Chart

Since December 1, 1998, Neurocrine Biosciences's market cap has increased from $124.10M to $14.14B, an increase of 11,297.69%. That is a compound annual growth rate of 20.42%.

Market Cap History

Date	Market Cap	% Change
May 20, 2024	14.26B	-0.45%
May 17, 2024	14.32B	0.27%
May 16, 2024	14.28B	-0.06%
May 15, 2024	14.29B	2.54%
May 14, 2024	13.94B	1.71%
May 13, 2024	13.70B	-0.40%
May 10, 2024	13.76B	-2.12%
May 9, 2024	14.06B	0.46%
May 8, 2024	13.99B	-2.91%
May 7, 2024	14.41B	1.04%
May 6, 2024	14.26B	0.71%
May 3, 2024	14.16B	0.63%
May 2, 2024	14.07B	-2.24%
May 1, 2024	14.39B	5.17%
Apr 30, 2024	13.69B	-0.97%
Apr 29, 2024	13.82B	2.13%
Apr 26, 2024	13.53B	-1.29%
Apr 25, 2024	13.71B	-0.87%
Apr 24, 2024	13.83B	-0.80%
Apr 23, 2024	13.94B	4.81%
Apr 22, 2024	13.30B	1.26%
Apr 19, 2024	13.14B	-0.41%
Apr 18, 2024	13.19B	-0.52%
Apr 17, 2024	13.26B	0.18%
Apr 16, 2024	13.23B	0.95%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Laboratory Corporation of America Holdings	17.31B
Illumina	17.14B
Quest Diagnostics	15.92B
BioMarin Pharmaceutical	14.69B
Walgreens Boots Alliance	14.39B
Revvity	13.97B
Natera	13.29B
Viatris	13.05B

Market Cap Rankings